【摘要】 目的:评价新生儿重症监护室(neonatal intensive care unit,NICU)开展临床治疗药学监护对抗感染的疗效及其对治疗满意度的影响。方法:选取2015年2月—2016年10月期间收治的NICU患者资料200例为未药学监护组,另选取2017年2月—2018年10月期间收治的NICU患者200例资料为药学监护组,比较两组患儿不同药学监护后感染发生率及其对治疗的满意度差异。结果:药学监护组200例患儿中12例发生感染(呼吸道、皮肤、胃肠道、口腔和其他感染),其发生率(6.00%)明显低于未药学监护组(27.00%()P<0.05);患儿家属对治疗的满意度高于未药学监护组(P<0.05)。结论:在NICU开展药学监护有效降低了患儿的感染发生率,提高了家属对治疗的满意度。更多还原

【Abstract】 Objective: To evaluate the influence of pharmaceutical care on efficacy of clinical anti-infection medication in neonatal intensive care unit(NICU) and its satisfaction on treatment. Methods: The data of 200 NICU patients admitted from February 2015 to October 2016 were selected as the non-pharmaceutical care group, and the data of 200 NICU patients admitted fom February 2017 to October 2018 were selected as the pharmaceutical care group. The differences of the incidence of infection and satisfaction with treatment between the two groups were compared. Result:Among the 200 cases in the pharmaceutical care group, 12 cases were infected respiratory tract, skin, gastrointestinal tract, oral cavity and other infections, and the incidence rate(6.00%) was significantly lower than that in the non-pharmaceutical care group(27.00%)(P<0.05). The family members of the patients were more satisfied with the treatment than the non-pharmaceutical care group(P<0.05). Conclusion: Anti-infection pharmaceutical care could effectively reduce the incidence of infection, and the satisfaction rate of family members in NICU were improved.更多还原